Barclays’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $9.31M | Sell |
42,800
-234,500
| -85% | -$52M | ﹤0.01% | 1493 |
|
|
2025
Q4 | $63.4M | Sell |
277,300
-8,800
| -3% | -$2M | 0.02% | 669 |
|
|
2025
Q3 | $66.2M | Buy |
286,100
+260,000
| +996% | +$52.9M | 0.01% | 640 |
|
|
2025
Q2 | $4.84M | Sell |
26,100
-57,800
| -69% | -$10.7M | ﹤0.01% | 2166 |
|
|
2025
Q1 | $17.6M | Sell |
83,900
-101,400
| -55% | -$19.7M | 0.01% | 1102 |
|
|
2024
Q4 | $32.9M | Buy |
185,300
+103,200
| +126% | +$19M | 0.01% | 842 |
|
|
2024
Q3 | $16.2M | Sell |
82,100
-217,700
| -73% | -$40.6M | ﹤0.01% | 1180 |
|
|
2024
Q2 | $51.4M | Buy |
299,800
+233,658
| +353% | +$38.7M | 0.02% | 611 |
|
|
2024
Q1 | $12M | Sell |
66,142
-48,658
| -42% | -$8.39M | ﹤0.01% | 1260 |
|
|
2023
Q4 | $17.8M | Buy |
+114,800
| New | +$16.7M | 0.01% | 1117 |
|
|
2023
Q2 | – | Sell |
-95,400
| Closed | -$15.2M | – | 4501 |
|
|
2023
Q1 | $15.2M | Sell |
95,400
-158,100
| -62% | -$24.2M | 0.01% | 973 |
|
|
2022
Q4 | $41M | Buy |
253,500
+218,100
| +616% | +$33.4M | 0.02% | 580 |
|
|
2022
Q3 | $4.75M | Buy |
+35,400
| New | +$5.08M | 0.01% | 1200 |
|
|
2022
Q1 | – | Sell |
-39,400
| Closed | -$5.33M | – | 4877 |
|
|
2021
Q4 | $5.33M | Buy |
+39,400
| New | +$4.65M | ﹤0.01% | 1663 |
|
|
2021
Q3 | – | Sell |
-286,100
| Closed | -$32.2M | – | 4720 |
|
|
2021
Q2 | $32.2M | Buy |
+286,100
| New | +$32.2M | 0.02% | 681 |
|
|
2021
Q1 | – | Sell |
-482,780
| Closed | -$51.7M | – | 4632 |
|
|
2020
Q4 | $51.7M | Buy |
482,780
+362,000
| +300% | +$34.8M | 0.03% | 451 |
|
|
2020
Q3 | $10.6M | Sell |
120,780
-23,270
| -16% | -$2.19M | 0.01% | 1013 |
|
|
2020
Q2 | $14.1M | Sell |
144,050
-112,050
| -44% | -$9.87M | 0.01% | 794 |
|
|
2020
Q1 | $19.5M | Sell |
256,100
-568,600
| -69% | -$48.4M | 0.02% | 652 |
|
|
2019
Q4 | $73M | Buy |
824,700
+320,500
| +64% | +$26.6M | 0.04% | 362 |
|
|
2019
Q3 | $38.2M | Buy |
504,200
+148,900
| +42% | +$10.2M | 0.02% | 561 |
|
|
2019
Q2 | $25.8M | Buy |
355,300
+148,900
| +72% | +$11.7M | 0.02% | 791 |
|
|
2019
Q1 | $16.6M | Buy |
206,400
+72,500
| +54% | +$5.93M | 0.01% | 949 |
|
|
2018
Q4 | $12.3M | Sell |
133,900
-122,200
| -48% | -$10.7M | 0.01% | 1032 |
|
|
2018
Q3 | $24.2M | Sell |
256,100
-52,400
| -17% | -$4.97M | 0.02% | 750 |
|
|
2018
Q2 | $28.6M | Buy |
308,500
+9,800
| +3% | +$957K | 0.02% | 609 |
|
|
2018
Q1 | $28.3M | Buy |
298,700
+97,500
| +48% | +$10.7M | 0.02% | 682 |
|
|
2017
Q4 | $19.5M | Sell |
201,200
-439,100
| -69% | -$41.4M | 0.02% | 819 |
|
|
2017
Q3 | $56.9M | Sell |
640,300
-5,400
| -0.8% | -$411K | 0.06% | 262 |
|
|
2017
Q2 | $46.8M | Sell |
645,700
-1,482,500
| -70% | -$99.7M | 0.05% | 296 |
|
|
2017
Q1 | $139M | Buy |
2,128,200
+1,615,038
| +315% | +$102M | 0.15% | 100 |
|
|
2016
Q4 | $32.1M | Buy |
513,162
+204,472
| +66% | +$12.5M | 0.03% | 399 |
|
|
2016
Q3 | $19.5M | Sell |
308,690
-91,700
| -23% | -$5.94M | 0.02% | 556 |
|
|
2016
Q2 | $24.8M | Buy |
400,390
+202,800
| +103% | +$12.4M | 0.03% | 435 |
|
|
2016
Q1 | $11.3M | Sell |
197,590
-486,870
| -71% | -$27.1M | 0.02% | 700 |
|
|
2015
Q4 | $40.4M | Sell |
684,460
-3,068,000
| -82% | -$177M | 0.05% | 344 |
|
|
2015
Q3 | $203M | Buy |
3,752,460
+2,989,480
| +392% | +$195M | 0.24% | 58 |
|
|
2015
Q2 | $51.1M | Sell |
762,980
-2,911,620
| -79% | -$190M | 0.06% | 290 |
|
|
2015
Q1 | $213M | Buy |
3,674,600
+1,056,600
| +40% | +$63.8M | 0.25% | 61 |
|
|
2014
Q4 | $170M | Buy |
2,618,000
+1,323,100
| +102% | +$83.4M | 0.16% | 89 |
|
|
2014
Q3 | $73.8M | Buy |
1,294,900
+1,159,000
| +853% | +$64.3M | 0.07% | 224 |
|
|
2014
Q2 | $7.61M | Sell |
135,900
-447,600
| -77% | -$23.5M | 0.01% | 1370 |
|
|
2014
Q1 | $29.8M | Buy |
583,500
+2,400
| +0.4% | +$121K | 0.03% | 490 |
|
|
2013
Q4 | $30.2M | Buy |
581,100
+308,700
| +113% | +$15.2M | 0.03% | 543 |
|
|
2013
Q3 | $12M | Buy |
272,400
+239,300
| +723% | +$10.6M | 0.01% | 1007 |
|
|
2013
Q2 | $1.37M | Buy |
+33,100
| New | +$1.45M | ﹤0.01% | 2972 |
|
Other funds holding ABBV
VCM
VPM
Barclays's ABBV Position: Q1 2026 in Review
Barclays increased its AbbVie (ABBV) stake by 15% in Q1 2026, buying an estimated $162M and bringing the position to 5,571,610 shares worth $1.21B. The position accounts for 0.29% of the portfolio, ranked #46.
Barclays first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Barclays held 5,571,610 shares of AbbVie worth $1.21B as of Q1 2026.
- Barclays bought 731,465 AbbVie shares in Q1 2026, an estimated $162M.
- AbbVie made up 0.29% of Barclays's portfolio in Q1 2026, its #46 holding.
- Barclays first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
- 4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.